Helen Parry 💙 (@low_helen) 's Twitter Profile
Helen Parry 💙

@low_helen

Assoc Prof UoB/consultant haematologist UHB. UKRI/BCUK Clinician Scientist👉my lab researches vaccination, 🩸 cancer & immunodeficiency. Also @blooducation.

ID: 1469802169

linkhttp://blooducation.co.uk calendar_today30-05-2013 13:47:36

578 Tweet

1,1K Followers

522 Following

Helen Parry 💙 (@low_helen) 's Twitter Profile Photo

Thanks for inviting me BOPA Committee. Delighted to give an update on decision making in #CLL management. Impt given so much change in the past year.

Bita Fakhri (@bitafakhri) 's Twitter Profile Photo

Glad to see this published — ibrutinib-associated pericardial events across two landmark trials. onlinelibrary.wiley.com/doi/full/10.11…

Emma Searle (@dremmasearle) 's Twitter Profile Photo

What an experience presenting the first in combination data with Inobrodib Pom and Dex in easily the largest room I’ve ever spoken in! Fantastic to be part of the “into the future” myeloma session to finish off a great #ASH2024. Safe travels home all!

What an experience presenting the first in combination data with Inobrodib Pom and Dex in easily the largest room I’ve ever spoken in! Fantastic to be part of the “into the future” myeloma session to finish off a great #ASH2024. Safe travels home all!
Dr Peter Prinsley MP (@peterprinsley) 's Twitter Profile Photo

With universities unable to afford them, clinical academics across the country are being offered redundancy. These are the people who teach our doctors and conduct ground breaking research. More must be done to support them.

UoB School of Infection, Inflammation & Immunology (@uobinfectionsch) 's Twitter Profile Photo

New research led by Dr Helen Parry 💙 reveals #Cancer patients on BTKi therapy can safely continue treatment & receive a #COVID vaccination, as pausing therapy does not affect antibody response to the vaccine. ➡️Full news article: bit.ly/4lcF06Q

New research led by Dr <a href="/low_helen/">Helen Parry 💙</a> reveals #Cancer patients on BTKi therapy can safely continue treatment &amp; receive a #COVID vaccination, as pausing therapy does not affect antibody response to the vaccine.
➡️Full news article: bit.ly/4lcF06Q
NIHR Birmingham Biomedical Research Centre (@birminghambrc) 's Twitter Profile Photo

Results from a trial led by Dr Helen Parry 💙 show that #BloodCancer patients treated with Bruton Tyrosine Kinase inhibitors should continue taking the drug while having COVID-19 vaccinations, as pausing therapy doesn't improve antibody response to the vaccine birminghambrc.nihr.ac.uk/news-and-event…

Results from a trial led by Dr <a href="/low_helen/">Helen Parry 💙</a> show that #BloodCancer patients treated with Bruton Tyrosine Kinase inhibitors should continue taking the drug while having COVID-19 vaccinations, as pausing therapy doesn't improve antibody response to the vaccine
birminghambrc.nihr.ac.uk/news-and-event…
Medical Sciences (@oxfordmedsci) 's Twitter Profile Photo

NEWS: Blood cancer patients should continue treatment at time of COVID-19 vaccination NDORMS and Uni of Birmingham's trial showed no difference in antibody levels between those who paused their medication and those who continued their treatment as usual. medsci.ox.ac.uk/news/blood-can…

Blooducation (@blooducation) 's Twitter Profile Photo

Another podcast released 🤩 - the amazing Adrian Shields talks us through common immunological queries in haematology and how to manage them. From A&G advice to managing 2ndry immune def.. it’s all in there! Available on all the usual platforms and at blooducation.co.uk/portfolio/comm….

Another podcast released 🤩 - the amazing <a href="/immunologydoc/">Adrian Shields</a> talks us through common immunological queries in haematology and how to manage them. From A&amp;G advice to managing 2ndry immune def.. it’s all in there! Available on all the usual platforms and at blooducation.co.uk/portfolio/comm….
Graham Collins (@graham74gc) 's Twitter Profile Photo

It’s back and it’s online. The fantastic #lymphomaManagement course. With much thanks to LymphomaAction for their support as always. Do sign up to learn about state of the art management of this fascinating disease from international experts. #lymsm